GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sotac Pharmaceuticals Ltd (NSE:SOTAC) » Definitions » 6-Month Share Buyback Ratio

Sotac Pharmaceuticals (NSE:SOTAC) 6-Month Share Buyback Ratio : -0.45% (As of Sep. 2024 )


View and export this data going back to 2023. Start your Free Trial

What is Sotac Pharmaceuticals 6-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Sotac Pharmaceuticals's current 6-Month Share Buyback Ratio was -0.45%.


Competitive Comparison of Sotac Pharmaceuticals's 6-Month Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sotac Pharmaceuticals's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sotac Pharmaceuticals's 6-Month Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sotac Pharmaceuticals's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Sotac Pharmaceuticals's 6-Month Share Buyback Ratio falls into.


;
;

Sotac Pharmaceuticals 6-Month Share Buyback Ratio Calculation

Sotac Pharmaceuticals's 6-Month Share Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

6-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Mar. 2024 ) - Shares Outstanding (EOP) (Sep. 2024 )) / Shares Outstanding (EOP) (Mar. 2024 )
=(11.050 - 11.100) / 11.050
=-0.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sotac Pharmaceuticals  (NSE:SOTAC) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Sotac Pharmaceuticals 6-Month Share Buyback Ratio Related Terms


Sotac Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Plot No. PF-21, Near ACME Pharma, Opposite Teva Pharma Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110
Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.

Sotac Pharmaceuticals Headlines

No Headlines